Filing Details

Accession Number:
0001209191-23-024263
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-14 06:00:10
Reporting Period:
2023-04-13
Accepted Time:
2023-04-14 06:00:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Oncternal Therapeutics Inc. ONCT Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1269341 G Richard Vincent 12230 El Camino Real, Suite 230
San Diego CA 92130
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-13 30,000 $0.30 156,859 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,526 Indirect By Family Trust
Common Stock 1,834 Indirect By Child
Footnotes
  1. The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.2975 to $0.3000. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.